{
    "eid": "2-s2.0-85151112784",
    "title": "Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after Successful Treatment with Direct-Acting Antivirals",
    "cover-date": "2023-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "chronic hepatitis C infection",
        "fibrosis score",
        "liver cancer",
        "liver fibrosis",
        "liver steatosis",
        "liver-related complications",
        "transient elastography"
    ],
    "authors": [
        "Napas Rodprasert",
        "Tinn Hongboontry",
        "Chitchanok Cherdchoochart",
        "Roongruedee Chaiteerakij"
    ],
    "citedby-count": 0,
    "ref-count": 34,
    "ref-list": [
        "Evolving epidemiology of hepatitis C virus",
        "Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis",
        "Update on hepatitis C: Direct-acting antivirals",
        "Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges",
        "Direct antiviral agent treatment leads to rapid and significant fibrosis regression after HCV eradication",
        "Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response",
        "Association Between Sustained Virological Response and All-Cause Mortality Among Patients with Chronic Hepatitis C and Advanced Hepatic Fibrosis",
        "Long-term changes in liver elasticity in hepatitis C virus-infected patients with sustained virologic response after treatment with direct-acting antivirals",
        "Changes in hepatic fibrosis and incidence of HCC following direct-acting antiviral treatment of F3 chronic hepatitis c patients: A prospective observational study",
        "Progressive fibrosis significantly correlates with hepatocellular carcinoma in patients with a sustained virological response",
        "Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals",
        "HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma",
        "Sampling Variability of Liver Fibrosis in Chronic Hepatitis C",
        "Systematic review with meta-analysis: Non-invasive assessment of non-alcoholic fatty liver disease\u2014The role of transient elastography and plasma cytokeratin-18 fragments",
        "Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection",
        "Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases\u2013Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection",
        "EASL Recommendations on Treatment of Hepatitis C 2018",
        "EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u20142021 update",
        "Non-invasive evaluation of liver fibrosis using transient elastography",
        "Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases",
        "The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals",
        "Magnitude and Kinetics of Decrease in Liver Stiffness After Anti-viral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis",
        "Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon",
        "Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents",
        "A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis",
        "The diagnostic accuracy of Fibroscan\u00ae for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response",
        "Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C",
        "Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals",
        "Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals",
        "Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection",
        "Risk factors for liver decompensation and hcc in hcv-cirrhotic patients after daas: A multicenter prospective study",
        "Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals",
        "Small studies: Strengths and limitations"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}